Hikma Pharmaceuticals Share News (HIK)

TOP NEWS: Two Rate Setters Back Rate Rise, BOE Minutes Show

UPDATE 2-Hikma Pharma cuts revenue forecast for branded drugs

* First-half revenue rises 16 pct to $738 mln * Revenue in injectibles business rises 41 pct to $346 mln * Company to pay special dividend of 4 pence per share * Cuts revenue growth forecast for branded drugs business * Shares fall as much as 2.3 percent (Adds CFO, analy

Hikma revenue lifted by strong injectables performance

A strong performance by its injectables business helped drive first half revenue growth of 16% at pharmaceuticals manufacturer Hikma. The business delivered a 41% jump in turnover, lifting group revenue from $638m to $738m and the gross margin from 55.3% to 59.8%. A good performance was seen acr

UK MORNING BRIEFING: Glencore Sets USD1 Billion Share Buyback

CORRECT: Hikma Pharmaceuticals Reiterates Guidance, Declares Special Dividend

Hikma Pharmaceuticals Reiterates Guidance, Declares Special Dividend

MARKET COMMENT: FTSE To Open Lower Amid Caution Ahead Of BoE Minutes

Hikma first-half profit jumps on strong injectibles sales

Aug 20 (Reuters) - Hikma Pharmaceuticals Plc reported a 44 percent rise in first-half adjusted profit, helped by strong demand for its high-margin injectibles particularly in the United States. Adjusted profit attributable to shareholders rose to $176 million in the six months ended June 3

UK Earnings, Trading Statements Calendar - Week Ahead

MARKET COMMENT: Shares Gain And Pound Falls On Tame UK Inflation

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead